| 注册
首页|期刊导航|中国药房|肿瘤疫苗临床研究的最新进展

肿瘤疫苗临床研究的最新进展

方罗 林能明

中国药房2012,Vol.23Issue(14):1253-1258,6.
中国药房2012,Vol.23Issue(14):1253-1258,6.DOI:10.6039/j.issn.1001-0408.2012.14.02

肿瘤疫苗临床研究的最新进展

Latest Progress of Clinical Research of Tumor Vaccine

方罗 1林能明1

作者信息

  • 1. 浙江省肿瘤医院,杭州310022
  • 折叠

摘要

Abstract

OBJECTIVE: To clarify the important significance of cost-effectiveness threshold for pharmacoeconomics and pharma-coeconomic evaluation from the perspective of net benefit. METHODS: Every kind of net benefit was introduced, and the internal relationship of net benefits and cost-effectiveness threshold was demonstrated on the theory and method point of view, and the significance of cost-effectiveness threshold to pharmacoeconomics was illustrated. RESULTS: There were 4 kinds of net benefits, and every kind of it was influenced by cost-effectiveness threshold. CONCLUSIONS: 4 kinds of net benefits are the function of cost-effectiveness threshold. Consequently, the sampling of cost-effectiveness threshold determines net benefits calculation directly.

关键词

肿瘤疫苗/Ⅲ期临床试验/综述

Key words

Cost-effectiveness threshold/Net benefit/Cost-effectiveness plane

分类

医药卫生

引用本文复制引用

方罗,林能明..肿瘤疫苗临床研究的最新进展[J].中国药房,2012,23(14):1253-1258,6.

基金项目

浙江省卫生高层次创新人才培养工程项目(20112015) (20112015)

中国药房

OACSCDCSTPCD

1001-0408

访问量0
|
下载量0
段落导航相关论文